Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Primary Axillary Hyperhydrosis. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 13];2(S1):S40. Available from: https://skin.dermsquared.com/skin/article/view/268